Variant report
Variant | rs623917 |
---|---|
Chromosome Location | chr8:61568210-61568211 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | STAT3 | chr8:61568170-61568333 | MCF10A-Er-Src | breast: | n/a | chr8:61568188-61568200 |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:61563711..61566471-chr8:61567487..61569836,4 | K562 | blood: | |
2 | chr8:61562515..61568989-chr8:61586860..61594946,37 | MCF-7 | breast: | |
3 | chr8:61559343..61568621-chr8:61588061..61597189,35 | MCF-7 | breast: | |
4 | chr8:61563005..61568398-chr8:61588453..61593214,14 | K562 | blood: | |
5 | chr8:61567081..61569634-chr8:62050277..62052303,2 | K562 | blood: | |
6 | chr8:61562616..61568326-chr8:61569044..61575643,11 | MCF-7 | breast: | |
7 | chr8:61563620..61565259-chr8:61566551..61570060,3 | K562 | blood: | |
8 | chr8:61562679..61568216-chr8:61588453..61593754,19 | K562 | blood: | |
9 | chr8:61567779..61569596-chr8:61570085..61572537,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254869 | TF binding region |
ENSG00000171316 | Chromatin interaction |
ENSG00000255289 | Chromatin interaction |
ENSG00000254869 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10090193 | 0.83[ASN][1000 genomes] |
rs2054670 | 0.87[ASW][hapmap];0.90[CHB][hapmap];0.95[CHD][hapmap];0.92[ASN][1000 genomes] |
rs2625442 | 0.98[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2680296 | 0.94[ASW][hapmap];0.81[CEU][hapmap];0.98[CHD][hapmap];0.93[GIH][hapmap];0.94[JPT][hapmap];0.87[LWK][hapmap];0.94[MKK][hapmap];0.93[TSI][hapmap];0.85[YRI][hapmap];0.87[AFR][1000 genomes];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2680297 | 0.88[CEU][hapmap];0.94[JPT][hapmap];0.87[AMR][1000 genomes];0.96[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs2680298 | 0.94[JPT][hapmap];0.95[YRI][hapmap];0.96[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs597123 | 0.88[CEU][hapmap];0.86[CHD][hapmap];0.80[GIH][hapmap];0.94[JPT][hapmap];0.93[TSI][hapmap];0.87[AMR][1000 genomes];0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs601778 | 0.90[CHB][hapmap];0.97[CHD][hapmap];0.86[GIH][hapmap];0.90[JPT][hapmap];0.87[TSI][hapmap];0.81[AMR][1000 genomes];0.84[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs605701 | 0.88[ASN][1000 genomes] |
rs608740 | 0.81[CEU][hapmap];0.93[CHD][hapmap];1.00[JPT][hapmap];0.80[TSI][hapmap];0.80[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs609264 | 0.94[JPT][hapmap] |
rs612558 | 0.94[JPT][hapmap] |
rs617434 | 0.81[CHB][hapmap];0.84[ASN][1000 genomes] |
rs618190 | 0.81[CHB][hapmap];0.93[CHD][hapmap];0.84[ASN][1000 genomes] |
rs622755 | 0.86[CHD][hapmap];0.83[JPT][hapmap];0.84[ASN][1000 genomes] |
rs623845 | 0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs625979 | 0.88[CEU][hapmap];0.94[JPT][hapmap];0.95[TSI][hapmap];0.88[AMR][1000 genomes];0.96[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs626913 | 0.94[JPT][hapmap] |
rs629523 | 0.84[JPT][hapmap];0.85[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs645067 | 0.88[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs645765 | 0.92[ASN][1000 genomes] |
rs657718 | 0.83[CHD][hapmap];0.84[GIH][hapmap];0.94[JPT][hapmap];0.86[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs658176 | 0.88[CEU][hapmap];0.86[CHD][hapmap];0.84[GIH][hapmap];0.94[JPT][hapmap];1.00[TSI][hapmap];0.92[AMR][1000 genomes];0.99[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs659805 | 0.82[ASN][1000 genomes] |
rs665893 | 0.94[ASW][hapmap];0.90[CHB][hapmap];0.95[CHD][hapmap];0.90[ASN][1000 genomes] |
rs671204 | 0.87[CEU][hapmap];0.83[JPT][hapmap];0.87[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs671576 | 0.88[CHD][hapmap];0.90[JPT][hapmap];0.87[TSI][hapmap];0.84[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs673802 | 0.82[AMR][1000 genomes];0.85[ASN][1000 genomes] |
rs685985 | 0.84[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs686852 | 0.81[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs7822621 | 0.83[CHD][hapmap];0.94[JPT][hapmap];0.87[TSI][hapmap];0.81[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv917756 | chr8:60942299-61862796 | Enhancers Weak transcription Active TSS Genic enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 74 gene(s) | inside rSNPs | diseases |
2 | nsv530383 | chr8:61431756-61605551 | Flanking Active TSS Active TSS Weak transcription Enhancers Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 30 gene(s) | inside rSNPs | diseases |
3 | nsv831335 | chr8:61497540-61688992 | Weak transcription Strong transcription Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
4 | nsv890945 | chr8:61522008-61707725 | Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
5 | nsv824657 | chr8:61555227-61626758 | Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
6 | nsv824658 | chr8:61561488-61612108 | Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 28 gene(s) | inside rSNPs | diseases |
7 | nsv525495 | chr8:61566655-61568210 | Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:61567200-61568400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
2 | chr8:61567200-61568800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr8:61567400-61573200 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
4 | chr8:61568200-61568400 | Bivalent Enhancer | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |